FDA recommends UCB reformulate Neupro; Exponential Pharma and Benu form new company;

> The FDA has recommended that UCB reformulate its Neupro® (Rotigotine Transdermal System) before making it available in the U.S. market for the treatment of Parkinson's disease (PD) and restless legs syndrome (RLS). Release

> Exponential Pharma Ventures and Benu Biopharma have announced the formation of a new company, LipimetiX, to develop a series of peptides therapeutics that mimic the function of Apolipoprotein E (Apo E), focused on lipid-lowering treatments for high-risk cardiovascular patients. Release

> The US Military Malaria Vaccine Program has presented results of its study using the Bioject Medical Technologies’ Biojector®2000 needle-free injection therapy system with a recombinant DNA vaccine at two recent conferences. Release

> Using its proprietary Locked Nucleic Acid (LNA) drug platform and drug discovery engine, Santaris Pharma A/S has advanced into drug development a discovery research candidate directed against PCSK9 (proprotein convertase subtilisin/kexin type 9), a new target for the treatment of high cholesterol. Santaris release

> Corealis Pharma, Inc. has consolidated its oral solid dosage formulation operations by acquiring a new 33,000 square-foot state-of-the-art pharmaceutical research facility in the Cité de la Biotech in Laval (Qc), Canada. Corealis release 

> Stemgent and Pfizer have announced a collaboration and research licensing agreement that will lead to certain research reagents developed or discovered by Pfizer being made available to the global research community through Stemgent. Pfizer release

Suggested Articles

RNA nanoparticles can squeeze into tumors and exit swiftly through the kidney, perfect for targeted delivery of cancer drugs, an OSU team says.

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.

Bexson Biomedical and Stevanato Group teamed up to develop a ketamine pump that may help patients better manage pain at home.